The US FDA has approved lenacapavir, a biannual injection by Gilead, to prevent HIV, potentially revolutionizing the fight against the epidemic.

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...

The Trump Administration made over two million dollars in cuts to the Southern Arizona AIDS Foundation, which means they are ...

Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...

The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...

The Wistar Institute has launched its HIV Cure and Viral Diseases Center with new lab space on Market Street and a plan to ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Co-infection involves the simultaneous infection of a host by two or more different pathogens, a common occurrence that ...

LIRA, Uganda (AP) — The bicycle parked in Lucy Abalo’s compound doesn’t belong to her. Any one of the hundreds of people in ...

Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...